Aptinyx discovers and develops
innovative therapies for
challenging disorders of the brain and
nervous system.

nerve 650

Our proprietary compounds modulate
the NMDA receptor,
a critical regulator
involved in nerve cell
communication.

We seek to leverage our experience and
track record of success to rapidly advance
promising therapies into clinical
development for patients in need.

About Aptinyx

Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. Learn more about Aptinyx »